Trials / Conditions / CAR-T Cell Immunotherapy
CAR-T Cell Immunotherapy
4 registered clinical trials studyying CAR-T Cell Immunotherapy.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients NCT03252171 | Fuda Cancer Hospital, Guangzhou | Phase 1 / Phase 2 |
| Withdrawn | CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients NCT04406610 | Fuda Cancer Hospital, Guangzhou | Phase 1 / Phase 2 |
| Withdrawn | CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients NCT02575261 | Fuda Cancer Hospital, Guangzhou | Phase 1 / Phase 2 |
| Withdrawn | CAR-T Cell Immunotherapy for HCC Targeting GPC3 NCT02723942 | Fuda Cancer Hospital, Guangzhou | Phase 1 / Phase 2 |